Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by newdaydawningon Jul 01, 2021 4:58pm
296 Views
Post# 33480038

RE:RE:RE:RE:RE:Nothing

RE:RE:RE:RE:RE:NothingExcellent post. The timelines you lay out are realistic and very credible. And your advice to hang tight is very prescient. Based on the science and the clinic, this will be a very different company - in a good way - a mere two years out.


stocksnbonds458 wrote: Agreed skys1, other than Dr Sherri the management and supporting cast are a bit of a gong show (refer to Phase 2 F-ups for clarification per said non-technical terminology). In spite of the assembled "Dream Team" her breakthrough will win out in the end. IMO we have an almost 2 year wait for "Breakthrough" FDA approval once we have our 20-25 phase 2 patients enrolled with which to collect the required data. So the 450 day clock starts ticking when we reach this critical number of enrolled phase 2 participants. Let's say the clock starts ticking Sept 1 at best. So 60 days from now, + 450 day data accumulation time + 60 days FDA approval time = 570 days from now. That works out to Feb 2023 if all goes well. Keep in mind they can apply for Breakthrough Status at any time during the 450 days, but for the purposes of this time-line I am assuming they won't jump the gun and submit incomplete data. I have been waiting 6 years, a few more won't kill me i quess.


<< Previous
Bullboard Posts
Next >>